Patent · US Active

Wearable automatic injection device for controlled delivery of therapeutic agents

US9180244B2 · kind B2 · utility

99Cited by

216References

43Claims

0Family size

Assignee

AbbVie Biotechnology Ltd. · BM

Inventors

Philip D. Anderson · Libertyville, US
Joseph F. Julian · Libertyville, US
Linas P. Laurusonis · Lake Villa, US
Timothy Parmer · Melbourne, US
Travis Yoch · Woodbury, US
Samuel M. Jang · Woodbury, US
Sean Corrigan · Chicago, US
Tomas Matusaitis · Chicago, US
William James Fienup · Chesterfield, US
Chris Strahm · DeForest, US

Key dates

Filing date	Apr 21, 2011
Grant date	Nov 10, 2015
Priority date	—
Expiry date	Sep 9, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2207/00
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Exemplary embodiments provide wearable automatic injection devices for subcutaneously injecting a therapeutic agent into a patient's body at controlled rates, for example, in a single bolus. Exemplary embodiments provide methods for assembling wearable automatic injection devices for subcutaneously injecting a therapeutic agent into a patient's body at controlled rates. Exemplary embodiments provide methods for using wearable automatic injection devices for subcutaneously injecting a therapeutic agent into a patient's body at controlled rates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.